Preparing for a Tsunami of Public Health Challenges

by The Honorable Jim Greenwood Biopharmaceutical companies are at the forefront of expanding our understanding of the genetic and biomolecular basis of disease, and their researchers are committed to developing the next generation of modern medicines. However, this goal can be realized only in an environment of forward-looking public policies that sustain scientific discovery and […]

The Right Target at the Right Time in Alzheimer’s Disease

by Reisa Sperling For so many years now, the focus of Alzheimer’s disease (AD) research has been on trying (and failing) to manage Alzheimer’s symptoms at later stages of the disease, rather than preventing these devastating symptoms from developing in the first place. And over the past ten years or so, as we are painfully […]

LEAD Coalition Urges Congressional Appropriators to Cement New Federal Investments in Research, Care and Support

Eighty-seven LEAD Coalition member organizations and supporters wrote to the U.S. House and Senate appropriations leadership urging them to include in the FY 2015 spending package the $100 million increase above FY 2014 levels for the National Institute on Aging (NIA) that the Senate appropriations committee included in its draft Labor, HHS and Education bill and the resources provided for […]